Axelle Basso-Bondini Named One of the 2019 PM360 Elite 100

PM360 has named senior media planner Axelle Basso-Bondini as one of the 2019 PM360 ELITE 100 in the Leader of the Future category. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today.

Read more about why Axelle was selected for this honor on PM360.

The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact to the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 17 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.

“The 100 individuals and teams we selected this year are truly worthy of being called ELITE,” says Anna Stashower, CEO and Publisher of PM360. “Each of them is at the forefront of their respective fields and are leading this industry in exciting and new directions. We are beyond excited to celebrate their achievements and provide the industry the chance to get to know them a little better.”

The winners were profiled in PM360’s May 2019 issue. You can read the profiles online at https://www.pm360online.com/the-2019-pm360-elite-100.

Axelle and the rest of the winners will be honored at a celebratory event on Tuesday, July 16th in New York City at the rooftop bar 230 FIFTH.

Online Video’s Vast Opportunities

Video has transformed online engagement across brands throughout almost every industry, and new approaches to content and delivery are poised to transform pharmaceutical media. According to AdWeek, pharma brands receive more shares and comments per video than any other type of content, and generally speaking, the market for online video is growing at an incredibly rapid rate. Forrester estimates that online video ads will grow from about 21% of the market in 2018 to 34% in 2023, rising alongside the amount of time consumers will spend watching streaming video…

In this month’s PM360, Jeffrey Erb discusses the opportunities and challenges engaging audeinces through video pose in the industry. Read the article.

 

 

 

 

MM&M and PRWeek Release Top 50 Health Influencers

Jeff ErbJeffrey Erb, president, HealixGlobal, was named to the Top 50 Health Influencer list compiled by MM&M and PRWeek.

As president of IPG media firm Healix, Jeffrey Erb understands how the pharma advertising world is changing and what opportunities that presents.

“What I find exciting about the industry is that it’s going through a significant amount of change,” he said in August.“What we do is really push people out of their comfort zone. We’re constantly looking at things differently and figuring out ways to evolve with the way the world is evolving and that is where you find your agency’s differentiation.”

As the industry changes, it gives healthcare agencies the chance to push boundaries in a sector that is traditionally more conservative, Erb said. He is also actively trying to make the industry better, helping form a consortium for media buyers in the point-of-care sector.

He has led Healix since April 2016. Before that, his career jumped between film production companies and marketing firms.

On the marketing side, Erb has recently worked at Digital Brand Expressions, Alliance Life Sciences, and Harte-Hanks, among others. He has also cofounded two production studios, Ironbound Studios Minnesota and Framelight.

For the list of Top 50 Health Influencers, click here.

Jeffrey Erb named DTC Innovator 2018

Jeffrey D. Erb, has created a culture of innovation at HealixGlobal — status quo is not in our vocabulary. He constantly encourages his team to look for ways to adjust our thinking and that of our clients to break down barriers and expand the reach of our clients’ brands.

Jeff is changing healthcare media buying with the incorporation of psychological and behavioral data to improve targeting and engagement – something that has been elusive in this highly regulated industry. He is responsible for organizing this move to bring unprecedented levels of qualitative and quantitative analytics to the forefront of the creative planning process through the development of Healix’s proprietary analytics tool, DNA. DNA allows us to layer traditional qualitative marketing data with the psychology of human qualitative engagement and allow us to see not only the what, where, when and how people engage with a communication program, but also the “why” people engage the way they do — all anonymously and within HIPAA guidelines. This gives brands a tool to better understand how their messages are driving openness to recommendations and, ultimately, scripts.

Jeff was honored at the awards reception held October 9 at the 2018 DTC Forum on Social Media & Technology.

For a list of all honorees, click here.

Long Live Point of Care

Even after the implosion of Outcome Health painted a shroud of distrust over the entire point of care media industry, the demand for in-office media solutions targeting both patients and physicians far exceeds the supply. Groups such as PoC3 have been established to help police ethical best practices and standards, and companies such as PlaceBridge have been launched to provide independent third-party auditing and verification for the media in-market, which will help bring back client confidence. However, while other well-established companies pride themselves in a reputable alternative solution, there remains a gap in the total inventory available to be able to reach the patient at the point of care…

In the lastest issue of PM36o, Jeffrey Erb, president of HealixGlobal, discusses the need for healthcare and pharmaceutical companies to take these solutions seriously, as they represent a growing patient engagement and distribution platform. Read the article here.

Jeffrey Erb & Luigi Camacho Named to PM360 Elite 100

PM360 ELITE 100 recognizes individuals and teams in the healthcare and life sciences industries who are making the most impact. This year, two members of the Healix team were honored to be recognized.

Jeff ErbJeffrey Erb, president of Healix, was name a Transformational Leader. Jeff has fostered a strong corporate culture at Healix that emphasizes collaboration and innovation. In the short 2 years since Healix was formed, he has doubled the agency’s client listRead more about what makes Jeff stand out here.

 

Luigi Camacho, media planning supervisor, was named a Leader of the Future. “Luigi doesn’t over delegate and doesn’t micro-manage,” explains his manager, Scott Cofsky, vice president of Media Strategy. “He creates a balance that leads to an independent team. He teaches them so they can be successful in their roles and creates opportunities for the team to learn and grow in a supportive environment.” Luigi was also the first recipient of Healix’s ACE Award for Innovation. Read more about Luigi here.

You can see all the honorees on PM360’s website.

MOMA Awards Finalist in 2 Categories

The MOMAs celebrate the brands and agencies delivering the best campaigns and strategies that are leading the way in mobile.

We are so proud to be a finalist with our client Merck Animal Health and partner Jun Group in The Drum MOMA Awards for Most Effective Mobile Advertising Campaign and Mobile Sales Promotion/Lead Generation/Direct Response Strategy!

We are looking forward to the award ceremony on May 17th in London to find out who the winners are. To see all the nominees or learn more about The Drum MOMA Awards, go to www.momas.co.uk.